This section outlines the extensive clinical expertise and innovative endovascular techniques developed for treating complex cardiovascular conditions, including high-risk coronary procedures and novel access closure solutions. Complex high risk coronary interventional procedures (CHIP) 1,000+ cases encompassing the full spectrum of advanced coronary intervention: * Left main interventions * Chronic total occlusions
This section documents the innovative clinical breakthroughs, patented medical devices, and novel treatment protocols developed at the Dysautonomia Research Institute, representing over three decades of advancement in cardiovascular and autonomic medicine. Dr. Adiraju has extensive experience in coronary and endovascular interventions. Over the last 33 years, Dr. Adiraju has performed
Dr. Adiraju holds prestigious faculty positions and clinical assignments at international institutions, contributing to the global advancement of interventional cardiology and autonomic medicine. Key Appointments & Faculty Roles * Invited Faculty, Joint Interventional Meeting (JIM), 2013 Rome, Italy * Course Co-Director, Asia Pacific Vascular Interventional Course (APVIC), New Delhi, India-2014, 2015, 2016,
The Dysautonomia Research Institute, founded by Dr. Ramesh Adiraju in 2005, is a clinical research and innovation center focused on advancing treatment protocols for dysautonomia and complex cardiovascular conditions. Dr. Ramesh Adiraju, MD, FACC Co-Founder & Chief Medical Officer, Autonomic Health Founder, Dysautonomia Research Institute Dr. Ramesh Adiraju is a
Heart failure with reduced ejection fraction (HFrEF) is a rapidly growing cardiovascular problem with ongoing research for optimal solutions. Congestive heart failure is the final common pathway for most cardiovascular illnesses. The number of adults in the U.S. living with heart failure rose by approximately 800,000 from 5.
What happens when our autonomic nervous system gets out of balance? Our highly complex body is kept functioning efficiently under widely varying physical and emotional conditions by a central control system continuously running in the background. This is the autonomic nervous system and the Hypothalamus - central vagal axis or
A comprehensive collection of peer-reviewed articles, research abstracts, and featured presentations documenting advancements in cardiovascular interventions, autonomic dysfunction, and endovascular therapies. Percutaneous Cutting Balloon Valvuloplasty Ramesh Adiraju Abstract #3 — The Lancet / JACC 1st Asia Pacific Cardiovascular Summit: Breakthroughs and Controversies 9–11 July 2011, Hong Kong, China Optimal STEMI Therapy
Based on our dysautonomia research, we have identified ME/CFS syndrome as a classic condition due to autonomic imbalance. There is recent reporting on a commonality between ME/CFS and post COVID syndrome. We have identified specific abnormalities, similar to ME/CFS patients with post COVID syndrome, using the ANS
Most medical decisions are based on population averages. Clinical guidelines come from large cohort studies. Biomarker reference ranges represent statistical distributions across populations. Treatments are standardized for broad patient groups. This approach has produced enormous medical progress. But it has an inherent limitation. Population averages cannot fully represent individual physiology.
Once disease appears, modern medicine typically treats the symptoms. Blood pressure medications lower blood pressure. Anti-inflammatory drugs suppress inflammatory markers. Sleep medications induce sedation. Anti-anxiety medications dampen stress responses. These treatments can be valuable and often life-saving. But they usually target outputs of a dysregulated system, not the system itself.
Most medicine detects disease late. Blood tests measure downstream biomarkers. Imaging detects organ damage. Clinical symptoms appear only after the body has already been under physiological stress for years. By the time most diseases are diagnosed, the underlying regulatory dysfunction has often been progressing silently. The problem is not that
Physical anxiety symptoms often stem from sympathetic overdrive rather than purely psychological causes. When the 'fight or flight' switch gets stuck in the ON position.